Guillaume Béraud:
ORCID: https://orcid.org/0000-0002-4705-0916
Role: ConceptualizationRole: MethodologyRole: SupervisionRole: ValidationRole: Writing
– original draftRole: Writing – review & editing
Jean-François Timsit: Role: ConceptualizationRole: MethodologyRole: SupervisionRole: ValidationRole: Writing
– original draftRole: Writing – review & editing
Henri Leleu: Role: ConceptualizationRole: Formal analysisRole: MethodologyRole: SupervisionRole:
ValidationRole: Writing – original draftRole: Writing – review & editing
James Mockridge: Role: Editor
Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS One
Journal ID (publisher-id): plos
Title:
PLoS ONE
Publisher:
Public Library of Science
(San Francisco, CA USA
)
ISSN
(Electronic):
1932-6203
Publication date
(Electronic):
12
January
2022
Publication date Collection: 2022
Publication date PMC-release: 12
January
2022
Volume: 17
Issue: 1
Electronic Location Identifier: e0262462
Affiliations
[1
]
Infectious Diseases Department, University Hospital of Poitiers, Poitiers, France
[2
]
APHP- Bichat Hospital—Medical and Infectious Diseases Intensive Care Unit, Paris,
France
[3
]
IAME UMR 1137 Université de Paris (Paris-Diderot), Paris, France
[4
]
Public Health Expertise, Paris, France
PLOS: Public Library of Science, UNITED KINGDOM
Author notes
Competing Interests: I have read the journal’s policy and the authors of this manuscript have the following
competing interests: - GB participated to advisory boards and gave lectures in symposia
for Gilead. - JFT reports participation to advisory board for Gilead related to covid-19
antiviral therapies. - HL is employed by PHE which received funding from Gilead. This
does not alter our adherence to PLOS ONE policies on sharing data and materials.
Author information
Article
Publisher ID:
PONE-D-21-17081
DOI: 10.1371/journal.pone.0262462
PMC ID: 8754316
PubMed ID: 35020746
SO-VID: 1043d7b7-70c7-4981-a885-f8f4e05356b3
Copyright © © 2022 Béraud et al
License:
This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided
the original author and source are credited.
Funded by:
funder-id http://dx.doi.org/10.13039/100005564, Gilead Sciences;
Award Recipient
:
Henri Leleu
HL is an employee of Public Health Expertise, which received funding from GILEAD for
this study. The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Subject:
Research Article
Subject:
Physical Sciences
Subject:
Chemistry
Subject:
Chemical Elements
Subject:
Oxygen
Subject:
Medicine and Health Sciences
Subject:
Medical Conditions
Subject:
Infectious Diseases
Subject:
Viral Diseases
Subject:
Covid 19
Subject:
Medicine and Health Sciences
Subject:
Health Care
Subject:
Health Care Facilities
Subject:
Hospitals
Subject:
People and places
Subject:
Geographical locations
Subject:
Europe
Subject:
European Union
Subject:
France
Subject:
Medicine and Health Sciences
Subject:
Health Care
Subject:
Health Care Facilities
Subject:
Hospitals
Subject:
Intensive Care Units
Subject:
Medicine and Health Sciences
Subject:
Medical Conditions
Subject:
Infectious Diseases
Subject:
Respiratory Infections
Subject:
Medicine and Health Sciences
Subject:
Medical Conditions
Subject:
Respiratory Disorders
Subject:
Respiratory Infections
Subject:
Medicine and Health Sciences
Subject:
Pulmonology
Subject:
Respiratory Disorders
Subject:
Respiratory Infections
Subject:
Medicine and Health Sciences
Subject:
Health Care
Subject:
Health Care Facilities
Subject:
Hospitals
Subject:
Hospitalizations
Subject:
Research and Analysis Methods
Subject:
Simulation and Modeling
Subject:
Agent-Based Modeling
Subject:
Computer and Information Sciences
Subject:
Systems Science
Subject:
Agent-Based Modeling
Subject:
Physical Sciences
Subject:
Mathematics
Subject:
Systems Science
Subject:
Agent-Based Modeling
